Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-01-16 @ 9:29 PM
Study NCT ID:
NCT04028518
Status:
UNKNOWN
Last Update Posted:
2019-07-22
First Post:
2019-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phaseâ…¡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.
Sponsor:
Angde Biotech Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-13
First Submit QC Date:
None
Study First Post Date:
2019-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-19
Last Update Post Date:
2019-07-22
Last Update Post Date Type:
ACTUAL